Podcast Episodes
Back to SearchVeterans and Interstitial Lung Disease: Providing Specialized Care in Rural and Underserved Areas
Episode 592
Drs. Kaul and Adegunsoye discuss Veterans Affairs’ innovative approach to understanding and treating pulmonary fibrosis among veterans by leveraging …
7 months, 4 weeks ago
Highlights From CHEST 2025: Proactive Intervention and Precision Medicine
Episode 591
Drs. Adegunsoye and Kaul review their takeaways from CHEST 2025, where pulmonary experts revealed a transformative approach to interstitial lung dise…
8 months ago
Should remission—not delay—be the new goal for prediabetes?
Episode 590
A long-term analysis of major prediabetes trials found that achieving remission or returning glucose levels to normal was associated with over a 50% …
8 months ago
Highlights From CHEST 2025: Earlier Detection and Targeted Interventions
Episode 589
CHEST 2025 showcased exciting advances in interstitial lung disease treatment, featuring new anti-fibrotic therapies and more personalized approaches…
8 months ago
Managing CNS Disease in HER2+ Breast Cancer
Episode 588
Drs. Drago and Traina explore the evolving landscape of managing central nervous system (CNS) metastases in HER2+ breast cancer, highlighting recent …
8 months ago
The Changing Landscape of Therapy in HER2-Low and Ultralow Breast Cancer (Part 2)
Episode 587
Dr. Drago and Dr. Traina continue their discussion of breakthrough developments in triple-negative breast cancer treatment, sharing highlights from t…
8 months, 1 week ago
What are the potential health and safety implications for children now that a CDC advisory panel has moved to withdraw the universal birth-dose recommendation for the hepatitis B vaccine in newborns?
Episode 586
The ACIP voted to replace universal newborn hepatitis B vaccination with shared clinical decision-making for infants of mothers who test negative, a …
8 months, 1 week ago
The Changing Landscape of Therapy in HER2-Low and Ultralow Breast Cancer (Part 1)
Episode 585
Dr. Tiffany Traina and Dr. Josh Drago discuss the evolving treatment landscape for HER2-low and ultralow breast cancer, highlighting how pivotal tria…
8 months, 1 week ago
Updated 2025 Recommendations: Allo-HCT and CAR T-Cell Therapy in CLL (Part 2)
Episode 584
Drs. Danilov and Coombs review the evolving treatment strategies for CLL, focusing on the use of CAR T-cell therapy and allogeneic stem cell transpla…
8 months, 2 weeks ago
Updated 2025 Recommendations: Allo-HCT and CAR T-Cell Therapy in CLL (Part 1)
Episode 583
Drs. Danilov and Coombs explore the potential benefits and challenges of CAR T-cell therapy in CLL, emphasizing the importance of personalized treatm…
8 months, 2 weeks ago